Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Robert Lyle

Concepts (109)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ductus Arteriosus, Patent
2
2019
38
0.320
Why?
DNA
1
2010
541
0.280
Why?
Asthma
1
2010
281
0.270
Why?
Intensive Care Units, Neonatal
2
2018
115
0.270
Why?
Infant, Premature
4
2019
318
0.220
Why?
Medicaid
2
2018
257
0.210
Why?
Disabled Children
2
2013
63
0.190
Why?
Infant, Newborn
7
2019
2772
0.180
Why?
Hospitalization
2
2017
652
0.170
Why?
Persistent Fetal Circulation Syndrome
1
2019
9
0.170
Why?
Chronic Disease
3
2011
567
0.160
Why?
Health Care Costs
2
2018
170
0.160
Why?
Infant, Low Birth Weight
1
2018
62
0.160
Why?
Child, Preschool
7
2018
3871
0.150
Why?
Continuity of Patient Care
1
2018
53
0.150
Why?
Clinical Protocols
1
2017
108
0.140
Why?
Immunologic Deficiency Syndromes
1
2016
20
0.140
Why?
Hypoglycemia
1
2016
51
0.140
Why?
Infant, Premature, Diseases
1
2017
94
0.130
Why?
DNA Copy Number Variations
2
2016
110
0.130
Why?
Child
8
2018
6847
0.130
Why?
Developmental Disabilities
1
2016
119
0.130
Why?
Hospitals, Pediatric
3
2013
239
0.120
Why?
Emergency Service, Hospital
1
2018
486
0.110
Why?
Comprehensive Health Care
1
2013
7
0.110
Why?
Infant
6
2018
3567
0.110
Why?
Blood Cells
1
2012
43
0.100
Why?
Genome, Human
1
2012
111
0.100
Why?
Child, Exceptional
1
2011
5
0.100
Why?
Cost Savings
1
2011
58
0.090
Why?
Parents
1
2013
314
0.090
Why?
Follow-Up Studies
2
2018
2182
0.090
Why?
Fetal Blood
1
2010
68
0.090
Why?
Gene Expression Regulation, Developmental
1
2010
138
0.090
Why?
Longitudinal Studies
3
2018
688
0.080
Why?
Genetic Association Studies
1
2010
117
0.080
Why?
Ambulatory Care
1
2011
222
0.080
Why?
Patient Care Team
1
2011
254
0.080
Why?
Time Factors
2
2018
2903
0.080
Why?
Outpatient Clinics, Hospital
1
2009
36
0.080
Why?
Health Knowledge, Attitudes, Practice
1
2013
488
0.080
Why?
Humans
13
2022
49974
0.080
Why?
Genotype
1
2010
537
0.080
Why?
Child Health Services
1
2009
77
0.080
Why?
Home Care Services
1
2009
73
0.080
Why?
Female
8
2018
26472
0.070
Why?
Polymorphism, Single Nucleotide
1
2010
485
0.070
Why?
Male
7
2018
25241
0.070
Why?
DNA Methylation
1
2010
548
0.070
Why?
Cohort Studies
3
2018
1422
0.060
Why?
Patient Discharge
2
2018
320
0.060
Why?
Prospective Studies
1
2010
2364
0.060
Why?
Embryonic Stem Cells
1
2022
15
0.050
Why?
Cell Differentiation
2
2022
651
0.050
Why?
Age Factors
2
2018
1087
0.050
Why?
Adolescent
3
2018
6356
0.050
Why?
Acetylcysteine
1
2002
100
0.050
Why?
Peptide Hydrolases
1
2002
62
0.050
Why?
Phosphoproteins
1
2002
107
0.050
Why?
Proteasome Endopeptidase Complex
1
2002
114
0.050
Why?
Adipocytes
1
2002
121
0.050
Why?
Arkansas
3
2013
1977
0.050
Why?
Cell Survival
1
2022
600
0.050
Why?
Neurons
1
2022
460
0.040
Why?
Proteins
1
2002
342
0.040
Why?
Time
1
2018
25
0.040
Why?
Ibuprofen
1
2018
21
0.040
Why?
Indomethacin
1
2018
38
0.040
Why?
United States
3
2018
4860
0.040
Why?
Cyclooxygenase Inhibitors
1
2018
39
0.040
Why?
Birth Weight
1
2019
120
0.040
Why?
Infant, Newborn, Diseases
1
2016
57
0.030
Why?
Patient Readmission
1
2018
219
0.030
Why?
Incidence
1
2018
1003
0.030
Why?
Logistic Models
1
2018
888
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2016
169
0.030
Why?
Databases, Factual
1
2018
658
0.030
Why?
Young Adult
2
2016
3958
0.030
Why?
Length of Stay
1
2018
619
0.030
Why?
Genomics
1
2016
286
0.030
Why?
Blood Glucose
1
2016
439
0.030
Why?
Risk Assessment
1
2018
1259
0.030
Why?
Health Care Surveys
1
2013
173
0.030
Why?
Twins, Monozygotic
1
2012
17
0.030
Why?
Individuality
1
2012
30
0.030
Why?
Patient-Centered Care
1
2013
129
0.020
Why?
Myelodysplastic Syndromes
1
2012
81
0.020
Why?
Aged
2
2016
9310
0.020
Why?
Cerebral Palsy
1
2010
40
0.020
Why?
Cost-Benefit Analysis
1
2011
274
0.020
Why?
Bronchopulmonary Dysplasia
1
2010
70
0.020
Why?
Multivariate Analysis
1
2011
577
0.020
Why?
Middle Aged
2
2016
12069
0.020
Why?
Adult
2
2016
13236
0.020
Why?
Quality of Life
1
2013
836
0.020
Why?
Program Evaluation
1
2009
354
0.020
Why?
Rural Population
1
2011
540
0.020
Why?
Mutation
1
2012
1294
0.020
Why?
Retrospective Studies
1
2018
6108
0.020
Why?
Aged, 80 and over
1
2012
3129
0.010
Why?
Treatment Outcome
1
2013
5141
0.010
Why?
Leupeptins
1
2002
7
0.010
Why?
Retinoblastoma-Like Protein p130
1
2002
8
0.010
Why?
Cysteine Proteinase Inhibitors
1
2002
22
0.010
Why?
Calpain
1
2002
25
0.010
Why?
Kinetics
1
2002
623
0.010
Why?
Nuclear Proteins
1
2002
242
0.010
Why?
Cell Line
1
2002
1000
0.010
Why?
Animals
1
2002
13187
0.000
Why?
Lyle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description